Predictive Oncology Inc. (POAI)

Business: Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States.

IPO Date: 29-Jan-2018

Chairman & CEO: Mr. J. Melville Engle

CFO & Sec.: Mr. Robert L. Myers

Listing: NASDAQ: POAI

Country: United States

Headquarters: Eagan, MN

Website: https://www.predictive-oncology.com

Market cap: $33.30 Mln

Revenue (TTM): $1.45 Mln

Earnings (TTM): $-19.14 Mln

Cash: $25.12 Mln

Total Debt: $0.70 Mln

Insider's Holding: 3.91%

Liquidity: Low

52 Week range: $0.25 - 1.47

Shares outstanding: 78,159,696

10 Years Aggregate:

• CFO: $-63.23 Mln
• EBITDA: $-113.24 Mln
• Net Profit: $-117.74 Mln